Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1992;79:940-944
© 1992 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ASSEL, B. G.
Right arrow Articles by JASSANI, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ASSEL, B. G.
Right arrow Articles by JASSANI, M. N.

Single-Operator Comparison of Early and Mid-Second-Trimester Amniocentesis

BARBARA G. ASSEL, MD, SUSAN M. LEWIS, BS, LOIS H. DICKERMAN, PhD, VICKI MURTIF PARK, PhD and MAJIDA N. JASSANI, MD

From the Department of Reproductive Biology, University MacDonald Womens Hospital, Case Western Reserve University, Cleveland, Ohio.

Abstract

We sought to determine whether early amniocentesis is a safe and acceptable method of genetic evaluation in early pregnancy. During the 54-month period from September 1986 to February 1991, 300 consecutive early second-trimester amniocenteses were performed transabdominally at 13–14 weeks' gestation and 567 consecutive mid-second-trimester transabdominal amniocenteses were performed at 16–18 weeks. Group assignment was nonrandomized, inter-operator-dependent variables were eliminated, and analysis was performed in one cytogenetics laboratory. The median maternal age and indications for the procedure were similar in both groups. There were no significant differences between the early-and mid-second-trimester amniocenteses in failed sampling, ambiguous results, pregnancy loss from 4 weeks after the procedure to 28 weeks' gestation, preterm birth, or perinatal death rate. Pregnancy loss within 4 weeks of amniocentesis was more frequent in early-than in mid-second-trimester amniocenteses. We conclude that early amniocentesis is a safe and acceptable method of genetic evaluation.




This article has been cited by other articles:


Home page
PediatricsHome page
C. Cunniff and and Committee on Genetics
Prenatal Screening and Diagnosis for Pediatricians
Pediatrics, September 1, 2004; 114(3): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S A Farrell, A M Summers, L Dallaire, J Singer, J.-A. M Johnson, and R D Wilson
Club foot, an adverse outcome of early amniocentesis: disruption or deformation?
J. Med. Genet., November 1, 1999; 36(11): 843 - 846.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Obstetricians and Gynecologists.